DCAT Week 2026

Join us to discuss how we can solve your API challenges

Meet us at New York City

23-26 March 2026
New York City, USA

Phone

Our Team at DCAT Week 2026

Deepak Sapra

CEO, Pharmaceutical Services and Active Ingredients

Dr. NM Sekhar

Vice President, API R&D

E Sreedhar

Executive Vice President, Global Regulatory Affairs

R Lalitha Kumari

Global Head of API Product Management & Head of Sales - US & Canada

Kalpesh Modi

Vice President, and Head – EU Market, API & B2B Collaborations

Juli Asmonga

Associate Vice President - Business Development, PSAI, North America

Ashish Rana

Regional Head, API, US & Canada

Dileep Kumar

API Sales and Marketing, North America

Rohan kaushik

Head, BD & Portfolio Management

About Dr.Reddy's API Business

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 250+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.

Dr. Reddy’s API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.

250+ APIs
8 Manufacturing sites
1970+ drug master files across global markets.
Over 325 ANDAs
Filed4500+ patents globally, out of which 1125 have been granted.
Experience with complex APIs and formulations supporting early market entries
Preferred pharma API supplier for pharma companies in more than 80 countries

Sustainability

Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world.

In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.

What we achieved in the past year:

Our Plants

Dr. Reddy’s Participation at DCAT Week 2026

DCAT Week 2026 is one of the most prominent annual gatherings for the global pharmaceutical and chemical manufacturing community. For Dr. Reddy’s Laboratories, it serves as a strategic platform to strengthen engagement with global partners, highlight capabilities, and reinforce its leadership in the API (Active Pharmaceutical Ingredients) space.

At DCAT, our API business plays a central role in showcasing Dr. Reddy’s end‑to‑end strengths—from a broad product portfolio and high-quality manufacturing to our commitment to sustainability and innovation across the value chain. The event enables our teams to conduct focused meetings with customers, suppliers, and industry collaborators to drive long‑term business growth.

What Dr. Reddy’s Does at DCAT Week 2026

Showcases a Robust API Portfolio
We present our extensive offering of 250+ high‑quality APIs across key therapeutic areas including oncology, cardiovascular, gastrointestinal, central nervous system, and anti-infectives. This demonstrates our capability to support diverse customer requirements globally.
Engages with Global Stakeholders
DCAT provides a forum for our commercial, sourcing, and leadership teams to interact with existing partners and explore new collaborations. These discussions often translate into strategic supply agreements and long-term business partnerships.
Drives Opportunities for Growth & Collaboration
Our teams use DCAT to identify emerging market needs, exchange insights on industry trends, and explore avenues for co-development, technology partnerships, and portfolio expansion.
Highlights Our Sustainability Vision
We take the opportunity to communicate our strong ESG performance, responsible manufacturing practices, and initiatives aimed at reducing environmental impact—reinforcing our commitment to a sustainable and resilient pharmaceutical supply chain.

Key Takeaways

DCAT Week is a high-impact platform for networking, strategic discussions, and business development within the pharmaceutical and chemical supply ecosystem.
Dr. Reddy’s API division leverages the event to strengthen relationships, showcase technical expertise, and drive growth in global API markets.
Our participation reflects a clear commitment to quality, innovation, operational excellence, and meaningful collaborations that support customers across the world.